ZTS 40.11 Zoetis Inc. Class A Common Stoc $ZTS Hit a 52

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 2:20 PM

ZTS 40.11 Zoetis Inc. Class A Common Stoc $ZTS Hit a 52 week high of 40.34 Currently at 40.11 -0.12 -0.30% With a day low of 40.06 and a total volume of 424,250.

ZTS Zoetis Inc. Class A Common Stoc Recent Headline News

These Statistics Demonstrate the Staggering and Undeniable Power of Pets
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 08, 1:41PM CST
Source: Flickr user Brad Holt. Pet ownership may not be for everyone, but it's becoming more prominent than you might have first thought. According to the American Pet Products Association, or APPA, pet ownership by household in the U.S. has...
ZTS: 40.18 (-0.05), PETS: 13.54 (+0.26), WOOF: 46.21 (+0.36), PETM: 72.50 (-0.04)

Comparing America's 3 Largest Generic Drugs Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 07, 9:05AM CST

ZTS: 40.18 (-0.05), ACT: 244.22 (-1.69), MYL: 53.89 (+0.78)

Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna
PR Newswire - Fri Nov 07, 7:55AM CST
Today, Analysts Review released its research reports regarding Medtronic, Inc. (NYSE: MDT), Zoetis Inc. (NYSE: ZTS), Biogen Idec Inc. (NASDAQ: BIIB), Tenet Healthcare Corp. (NYSE: THC) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7776-100free.
ZTS: 40.18 (-0.05), BIIB: 325.62 (+4.87), MDT: 68.49 (+0.39), THC: 48.39 (+0.54), AET: 83.30 (+1.01)

Zoetis to Participate in Piper Jaffray 26th Annual Healthcare Conference
Business Wire - Wed Nov 05, 7:30AM CST
Zoetis Inc.(NYSE:ZTS) will participate in the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, Dec. 2, in New York, N.Y. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Dr. Catherine Knupp, Executive Vice President and President, Research and Development, will represent the company and respond to questions from analysts. They are scheduled to present at 8:30 a.m. EST.
ZTS: 40.18 (-0.05)

Zoetis (ZTS) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Tue Nov 04, 6:36PM CST
The following Zoetis (ZTS) conference call took place on November 4, 2014, 08:30 AM ET. This is a transcript of that earnings call:
ZTS: 40.18 (-0.05)

Zoetis' (ZTS) CEO Juan Alaix on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 12:20PM CST

ZTS: 40.18 (-0.05)

Zoetis Q3 Earnings Beat Driven by Higher Livestock Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:50AM CST
Zoetis' (ZTS) third-quarter 2014 earnings (excluding special items) of 41 cents per share were above the Zacks Consensus Estimate of 37 cents.
ZTS: 40.18 (-0.05), ENDP: 68.76 (-0.20), VRX: 127.61 (+1.50), PFE: 30.20 (+0.28)

Zoetis beats 3Q profit forecasts
AP - Tue Nov 04, 8:33AM CST
FLORHAM PARK, N.J. (AP) — FLORHAM PARK, N.J. (AP) — Zoetis Inc. (ZTS) on Tuesday reported third-quarter profit of $166 million.
ZTS: 40.18 (-0.05)

Zoetis Reports Third Quarter 2014 Results
Business Wire - Tue Nov 04, 6:03AM CST
--Third Quarter 2014 Reported Net Income of $166 Million, or Diluted EPS of $0.33, Increased 27%, Compared to Third Quarter 2013
ZTS: 40.18 (-0.05)

Zoetis beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:02AM CST

ZTS: 40.19 (-0.04)

Zoetis (ZTS) Stock Gains Ahead of Third-Quarter Earnings Report
at The Street - Mon Nov 03, 2:52PM CST
Shares of Zoetis (ZTS) are gaining Monday ahead of the drug manufacturer's third-quarter earnings report before the market's open on Tuesday.
ZTS: 40.19 (-0.04)

Will Zoetis (ZTS) Pull a Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 4:10PM CDT
Zoetis Inc. (ZTS) is scheduled to report third-quarter 2014 results before the opening bell on Nov 4.
ZTS: 40.19 (-0.04), ACT: 244.13 (-1.78), PFE: 30.20 (+0.28), HSP: 56.05 (-0.27)

A Future Dividend Champion - Zoetis
DG Ruralist - at Seeking Alpha - Sat Oct 25, 6:22PM CDT

ZTS: 40.19 (-0.04), PFE: 30.20 (+0.28)

Third Point's Daniel Loeb Tells Amgen it's Time to Break up
at The Street - Wed Oct 22, 10:36AM CDT
Amgen plans to expound on plans for the company at its Oct. 28 investor meeting.
ZTS: 40.19 (-0.04), ABT: 43.98 (+0.61), PFE: 30.20 (+0.28), AMGN: 162.21 (+1.96), ABBV: 63.55 (+2.05)

Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt
PR Newswire - Mon Oct 20, 7:40AM CDT
Investor-Edge has initiated coverage on the following equities: Allergan Inc. (NYSE: AGN), Zoetis Inc. (NYSE: ZTS), Actavis PLC (NYSE: ACT), Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), and Mallinckrodt PLC (NYSE: MNK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 17, 2014, the NASDAQ Composite ended at 4,258.44, up 0.97%, the Dow Jones Industrial Average advanced 1.63%, to finish the day at 16,380.41, and the S&P 500 closed at 1,886.76, up 1.29%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 707.88, up 1.61%, with the index also advancing 0.29% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
MNK: 92.53 (+1.47), ZTS: 40.19 (-0.04), AGN: 195.00 (-1.00), AVNR: 13.20 (+0.18), ACT: 244.13 (-1.78)

Approval of Settlement, Philanthropic Activities, Partnership, Market Activity, and Dividend - Research Reports on Duke Energy, Lowe's, Viacom, Trinity and Zoetis
PR Newswire - Wed Oct 08, 8:20AM CDT
Today, Analysts Review released its research reports regarding Duke Energy Corp. (NYSE: DUK), Lowe's Companies, Inc. (NYSE: LOW), Viacom, Inc. (NASDAQ: VIAB), Trinity Industries Inc. (NYSE: TRN) and Zoetis Inc. (NYSE: ZTS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7017-100free.
ZTS: 40.19 (-0.04), DUK: 82.62 (+0.54), TRN: 35.80 (+0.10), LOW: 57.98 (+0.29), VIAB: 70.14 (-0.49)

Zoetis' board announces dividend of USD0.072 per share for Q4 2014
M2 - Fri Oct 03, 4:23AM CDT
The board of directors of Zoetis (NYSE:ZTS), an animal health company, on Friday declared a fourth quarter dividend of USD0.072 per share of the company's common stock.
ZTS: 40.19 (-0.04)

Zoetis Declares Fourth Quarter 2014 Dividend
Business Wire - Thu Oct 02, 4:10PM CDT
The Board of Directors of Zoetis Inc.(NYSE:ZTS) declared a fourth quarter dividend payable to holders of the company's common stock of $0.072 per share. The dividend is to be paid on Tuesday, Dec. 2, 2014, to holders of record on Wednesday, Nov. 5, 2014.
ZTS: 40.19 (-0.04)

Zoetis to Host Webcast and Conference Call on Third Quarter 2014 Financial Results
Business Wire - Tue Sep 30, 7:31AM CDT
Zoetis Inc.(NYSE: ZTS) will host a webcast and conference call at 8:30 a.m. (EST) on Tuesday, November 4, 2014. Chief Executive Officer Juan Ramon Alaix and Executive Vice President and Chief Financial Officer Paul Herendeen will review third quarter 2014 financial results and respond to questions from financial analysts during the call.
ZTS: 40.19 (-0.04)

Focusing Solely On Animal Health Sets Zoetis Apart
at Investor's Business Daily - Fri Sep 26, 1:37PM CDT
In April 2013, experts diagnosed a virus spreading quickly among America's pigs. It has since killed more than 7 million piglets in 30 states. By early summer of 2013, the leadership team at animal-health company Zoetis (ZTS) decided to develop a...
ZTS: 40.19 (-0.04), PFE: 30.19 (+0.27)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...